GlobalData on MSN9h
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use
The US Food and Drug Administration (FDA) has accepted Gilead’s new drug application (NDA) for lenacapavir and set a prescription drug user fee act (PDUFA) target action date of ...
unaids9h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
By paralyzing frontline response efforts led by community groups, the US decision to freeze funding is weakening health systems across the Global South. The freeze not only jeopardizes precious gains ...
A new HIV prevention drug could get FDA approval this year
Preventing HIV infections could soon be as simple as two shots a year.
Healio10h
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Utah Public Radio12h
A breakthrough HIV drug was developed using Utah biochemistry research
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
Researchers look for the best ways to help people with HIV quit smoking
Human immunodeficiency virus (HIV) treatment has gotten so good that people can take a pill once a day to achieve viral ...
unaids16h
UNAIDS Weekly Update – Impact of US Shifts on the Global HIV Response
As of 17 February 2024, UNAIDS had received at least one status report from 52 countries (39 PEPFAR-funded and 13 countries that receive some US support). The 39 countries represent 71% of all ...